Search Results

There are 11359 results for: content related to: Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis

  1. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  2. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 671–685, R. K. Sterling, A. Kuo, V. K. Rustgi, M. S. Sulkowski, T. G. Stewart, J. M. Fenkel, H. El-Genaidi, M. A. Mah'moud, G. M. Abraham, P. W. Stewart, L. Akushevich, D. R. Nelson, M. W. Fried and A. M. Di Bisceglie

    Version of Record online : 28 JAN 2015, DOI: 10.1111/apt.13095

  3. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  4. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  5. You have free access to this content
    Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 659–671, D. Joshi, I. Carey and K. Agarwal

    Version of Record online : 21 FEB 2013, DOI: 10.1111/apt.12260

  6. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  7. Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 951–974, Olga M. Klibanov, Shannon H. Williams, Lisa S. Smith, Jacqueline L. Olin and Stephen B. Vickery

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.951

  8. You have free access to this content
    UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 647–662, P. Ramachandran, A. Fraser, K. Agarwal, A. Austin, A. Brown, G. R. Foster, R. Fox, P. C. Hayes, C. Leen, P. R. Mills, D. J. Mutimer, S. D. Ryder and J. F. Dillon

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1365-2036.2012.04992.x

  9. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  10. You have free access to this content
    Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 2, July 2013, Pages: 124–133, M. Vera-Llonch, M. Martin, J. Aggarwal, M. Donepudi, M. Bayliss, T. Goss and Z. Younossi

    Version of Record online : 3 JUN 2013, DOI: 10.1111/apt.12354

  11. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x

  12. You have free access to this content
    Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 2, January 2014, Pages: 137–147, J. M. Wantuck, A. Ahmed and M. H. Nguyen

    Version of Record online : 19 NOV 2013, DOI: 10.1111/apt.12551

  13. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  14. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  15. You have free access to this content
    Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 9, November 2013, Pages: 1076–1085, E. Ogawa, N. Furusyo, M. Nakamuta, E. Kajiwara, H. Nomura, K. Dohmen, K. Takahashi, T. Satoh, K. Azuma, A. Kawano, Y. Tanabe, K. Kotoh, S. Shimoda, J. Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 17 SEP 2013, DOI: 10.1111/apt.12494

  16. You have free access to this content
    The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 431–439, Varun Garg, Gurudatt Chandorkar, Yijun Yang, Nathalie Adda, Lindsay McNair, Katia Alves, Frances Smith and Rolf P. G. van Heeswijk

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04345.x

  17. You have free access to this content
    Optimal treatment with telaprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 3–13, Arun B. Jesudian and Ira M. Jacobson

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12079

  18. The Pharmacokinetic Interaction Between an Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone and the HCV Protease Inhibitor Telaprevir

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1574–1583, Dr Varun Garg, Dr Rolf van Heeswijk, Dr Yijun Yang, Dr Robert Kauffman, Dr Frances Smith and Dr Nathalie Adda

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011419855

  19. You have free access to this content
    Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E163–E171, Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, Norio Akuta, Taito Fukushima, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 8 JAN 2014, DOI: 10.1111/hepr.12268

  20. Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma

    Biomedical Chromatography

    Volume 28, Issue 12, December 2014, Pages: 1714–1721, Xinhui Chen, Lane R. Bushman, Kevin J. McAllister, Peter L. Anderson and Jennifer J. Kiser

    Version of Record online : 24 APR 2014, DOI: 10.1002/bmc.3211